{
  "retracted": false,
  "timestamp": 1547251200000,
  "updates": [
    {
      "timestamp": 1574866219828,
      "identifier": {
        "doi": "10.1007/s40261-019-00748-x"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1007/s40261-018-0696-3"
  },
  "journal": "Clinical Drug Investigation",
  "publisher": "Springer Science and Business Media LLC",
  "title": "Correction to: Unexpected Benefit from Alpelisib and Fulvestrant in a Woman with Highly Pre-treated ER-Positive, HER2-Negative PIK3CA Mutant Metastatic Breast Cancer"
}
